Healthcare Brew explores how Angels for Change is addressing the national drug shortage crisis. From our Drug Shortage Hotline—which has helped patients access more than 750,000 medicines since 2022—to efforts that strengthen supply chains and raise awareness, the article highlights the urgent need for solutions and the impact of collaboration across patients, providers, and industry.
Angels for Change Statement Included in Congressional Hearing on Strengthening the U.S. Health Care Supply Chain
Last month, the House Energy & Commerce Health Subcommittee held a critical hearing titled: “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain.”
Angels for Change submitted a formal statement for the record—bringing the voice of the patient directly to policymakers.
New Legislation Takes Aim at Drug Shortages—Angels for Change Recognized in MAPS Act Launch
Angels for Change is officially recognized in the introduction of the bipartisan Mapping America’s Pharmaceutical Supply (MAPS) Act, a groundbreaking bill introduced by Representatives Doris Matsui (D-CA) and Dan Crenshaw (R-TX). This legislation directly addresses vulnerabilities in the drug supply chain by requiring greater transparency, mapping critical drug components, and identifying potential risks before they impact patient care
Every day clinicians wonder if they will have the necessary medicines to treat the patients they serve, which include pediatric cancer patients. Far too often, an oncologist has to treat a pediatric cancer patient with a therapy that is not optimal. As a parent, how would you like to hear that your child has cancer, but the best drug to treat your child is not available and that a suboptimal treatment must be administered? —Martin Van Trieste
Angels for Change has been working closely with the FDA to communicate updates on the recently reported vincristine crisis. We are pleased to announce that both the FDA and Pfizer have worked together to provide supply and updates to patients, providers and the community regarding this critical drug shortage.
